Dumanskiy Y, Bondar O, Stoliarchuk E. The Kі-67 marker for assessing the effectiveness of systemic or regional neoadjuvant polychemotherapy in patients with locally advanced breast cancer. Exp. oncol. [Internet]. 2023 Jun. 5 [cited 2025 Mar. 25];41(2):176-8. Available from: https://exp-oncology.com.ua/index.php/Exp/article/view/2019-2-14